CN Patent

CN101048164A — 降低肌萎缩性侧索硬化中神经变性的方法和组合物

Assigned to Individual · Expires 2007-10-03 · 19y expired

What this patent protects

本公开内容涉及一种或多种胆汁酸和水溶性淀粉转化产物或非淀粉多糖的澄清水溶液。本公开内容的溶液可结合对患有神经变性疾病和/或运动神经元疾病的对象具有治疗作用的药物化合物向对象施用。在一些实施方案中，所述疾病是肌萎缩性侧索硬化。

USPTO Abstract

本公开内容涉及一种或多种胆汁酸和水溶性淀粉转化产物或非淀粉多糖的澄清水溶液。本公开内容的溶液可结合对患有神经变性疾病和/或运动神经元疾病的对象具有治疗作用的药物化合物向对象施用。在一些实施方案中，所述疾病是肌萎缩性侧索硬化。

Drugs covered by this patent

sodium-phenylbutyrate (SODIUM PHENYLBUTYRATE)

Patent Metadata

Patent number: CN101048164A
Jurisdiction: CN
Classification: —
Expires: 2007-10-03
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.